A detailed history of Bridgeway Capital Management, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 90,305 shares of SERA stock, worth $734,179. This represents 0.02% of its overall portfolio holdings.

Number of Shares
90,305
Previous 86,105 4.88%
Holding current value
$734,179
Previous $509,000 38.31%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.29 - $8.43 $22,218 - $35,406
4,200 Added 4.88%
90,305 $704,000
Q4 2023

Feb 14, 2024

SELL
$1.65 - $6.85 $16,500 - $68,500
-10,000 Reduced 10.41%
86,105 $514,000
Q3 2023

Nov 14, 2023

BUY
$1.55 - $3.34 $35,340 - $76,152
22,800 Added 31.1%
96,105 $178,000
Q1 2023

May 15, 2023

BUY
$1.19 - $4.25 $87,232 - $311,546
73,305 New
73,305 $280,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $241M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.